Loading...

Home
ETF
SNY

SNY

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

SNY News

Sanofi Faces Leadership Change Amid Drug Pipeline Challenges

Sanofi CEO Transition Amidst Challenges

Sanofi Appoints New CEO Amid Board Changes

3d agoNASDAQ.COM

Sanofi Board Appoints New CEO Amid Transition

3d agoseekingalpha

NIH Discontinues Low-Dose Rivaroxaban Trial Amid Safety Concerns

Sanofi Invests $30M in GluBio to Support Sickle Cell Candidates

4d agoseekingalpha

Nektar Therapeutics Stock Soars on Positive Eczema Therapy Data

Moderna Faces FDA Setback on Influenza Vaccine Application

Oakmark International Strategy Q4 Underperformance Against Benchmark

5d agoseekingalpha

Sanofi's Rilzabrutinib Receives Breakthrough Therapy Designation

6d agoseekingalpha

Biogen Shares Increase Despite Falling Multiple Sclerosis Revenue and Ongoing Declines

Feb 06 2026Barron's

Cardinal Health Shares Surge Following Earnings Report as CEO Discusses Success Factors.

Feb 05 2026Barron's

Sanofi Announces €1B Share Buyback Program

Feb 03 2026seekingalpha

Sanofi Announces €1 Billion Share Buyback Program

Feb 03 2026Yahoo Finance

Sanofi's Venglustat Achieves Success in Gaucher Disease Trial

Feb 02 2026seekingalpha

Sanofi Violates UK Pharmaceutical Marketing Code

Feb 02 2026Benzinga